Alzheimer's disease clinical trials are pivotal in the ongoing battle against dementia. These trials test new treatments and therapies aimed at slowing or halting the progression of Alzheimer's, a degenerative brain disorder that impairs memory and cognitive functions. Researchers recruit participants to evaluate the safety and efficacy of experimental drugs or interventions, often comparing them to placebos or standard treatments. The goal is to discover breakthroughs that can improve quality of life for those affected by Alzheimer's and possibly find a cure. Participation in clinical trials not only offers potential benefits to patients but also advances scientific understanding of the disease. It's crucial for participants to be well-informed about the risks and potential outcomes before deciding to join, contributing to the collective effort in finding effective treatments for Alzheimer's disease.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China